Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes
McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, Mann JFE, Emerson SS, Poulter NR, Engelmann MDM, Ripa MS, Hovingh GK, Brown-Frandsen K, Bain SC, Cavender MA, Gislum M, David J-P, Buse JB, for the SOUL Study Group
N Engl J Med 2025 March 29, epub ahaed of print.
bővebben >>